FdaApplication
NDA 021254
Identifiers
- fda_app_no: NDA021254
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE |
| application_type | NDA |
| approval_date | 2006-06-08 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ADVAIR HFA | FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | 0.115MG/INH;EQ 0.021MG BASE/INH | AEROSOL, METERED;INHALATION |
| ADVAIR HFA | FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | 0.045MG/INH;EQ 0.021MG BASE/INH | AEROSOL, METERED;INHALATION |
| ADVAIR HFA | FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | 0.23MG/INH;EQ 0.021MG BASE/INH | AEROSOL, METERED;INHALATION |
3 products